Chevy Chase Trust Holdings LLC Sells 10,220 Shares of MetLife, Inc. (NYSE:MET)

Chevy Chase Trust Holdings LLC lessened its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 3.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 306,915 shares of the financial services provider's stock after selling 10,220 shares during the period. Chevy Chase Trust Holdings LLC's holdings in MetLife were worth $25,130,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. MeadowBrook Investment Advisors LLC grew its position in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock worth $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new position in MetLife in the 3rd quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC bought a new position in MetLife in the 4th quarter worth about $32,000. Institutional investors own 94.99% of the company's stock.

MetLife Price Performance

MET stock traded up $0.65 on Wednesday, hitting $83.08. 2,793,089 shares of the company's stock traded hands, compared to its average volume of 3,647,594. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The stock has a market cap of $57.53 billion, a price-to-earnings ratio of 13.92, a P/E/G ratio of 0.64 and a beta of 1.07. The stock has a fifty day moving average of $83.41 and a 200-day moving average of $81.23. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, analysts forecast that MetLife, Inc. will post 9.66 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio is 36.52%.

Analyst Ratings Changes

Several research analysts have commented on the stock. Keefe, Bruyette & Woods decreased their target price on shares of MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research report on Wednesday, February 12th. TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a research note on Wednesday, November 27th. StockNews.com lowered shares of MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Wells Fargo & Company upped their price target on shares of MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a research note on Wednesday. Finally, Barclays reduced their price target on shares of MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a research note on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, MetLife has a consensus rating of "Moderate Buy" and an average price target of $92.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.